Načítá se...
Second‐Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review
The management of advanced clear‐cell renal cell carcinoma has steadily improved over the past decade with the introduction of antiangiogenic and targeted therapies. Recently, three new therapies have been approved for use as second‐line options that further advance the treatment armamentarium: nivo...
Uloženo v:
| Vydáno v: | Oncologist |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AlphaMed Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5947457/ https://ncbi.nlm.nih.gov/pubmed/29487224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0534 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|